Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Arcutis Biotherapeutics, Inc. (ARQT) had Return on Equity of 6.80% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$129.86M |
|
$15.01M |
|
$10.94M |
|
$118.92M |
|
$113.43M |
|
$16.43M |
|
$-1.28M |
|
$15.14M |
|
$15.14M |
|
$15.01M |
|
$15.01M |
|
$15.01M |
|
$15.01M |
|
$16.43M |
|
$16.77M |
|
130.52M |
|
135.90M |
|
$0.11 |
|
$0.11 |
|
| Balance Sheet Financials | |
$467.67M |
|
$0.87M |
|
$20.87M |
|
$488.54M |
|
$160.34M |
|
$101.95M |
|
$107.62M |
|
$267.96M |
|
$220.58M |
|
$206.89M |
|
$220.58M |
|
125.59M |
|
| Cash Flow Statement Financials | |
$14.88M |
|
$-26.56M |
|
$3.06M |
|
$43.22M |
|
$34.43M |
|
$-8.79M |
|
$23.45M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
0.32 |
|
0.49 |
|
91.58% |
|
12.65% |
|
12.65% |
|
-- |
|
11.66% |
|
11.56% |
|
$14.72M |
|
-- |
|
-- |
|
-- |
|
0.27 |
|
0.28 |
|
0.84 |
|
107.53 |
|
|
Return on Equity |
6.80% |
7.25% |
|
3.07% |
|
4.65% |
|
$1.76 |
|
$0.11 |
|
$0.11 |
|